RxDoctor Payments DataLook up a doctor →

Michael McClung

Endocrinology, Diabetes & Metabolism · Portland, ORNPI 1477580207

Payments from drug & device makers

$1,325,868in general payments, 2019–2025

Across 1,427 payments — averaging $929.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1.3M
  • AstraZeneca$21K
  • Kyowa Kirin, Inc.$9K
  • UCB SA$8K
  • Novo Nordisk$6K
  • Radius Health, Inc.$6K
  • plus $12K from 10 others
$28,911in research payments, 2019–2025

Across 12 payments — averaging $2409.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$19K
  • E.r. Squibb & Sons, L.L.C.$10K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,325,868 in reported general payments places this provider in the 95th percentile of 76 endocrinology, diabetes & metabolism providers in Oregon.

See all endocrinology, diabetes & metabolism providers in Oregon

Other endocrinology, diabetes & metabolism in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →